Analyst Ratings for Atea Pharmaceuticals (AVIR) [Buys]
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/25/2020 | Evercore ISI | Umer Raffat | New Coverage | Outperform (N/A) |
N/A (N/A) |
34.07 (3.73) |
-89.05% | Details |
| 11/24/2020 | William Blair » Updated 10/19/2021 |
Tim Lugo | New Coverage | Outperform (N/A) |
N/A (N/A) |
33.54 (3.73) |
-88.88% | Details |
